I 

118TH CONGRESS 

2D SESSION H. R. 8999 

To amend title XVIII of the Social Security Act to provide coverage and 

payment under such title for certain treatments for dialysis-related amyloidosis, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 11, 2024 

Mr. BABIN (for himself, Mr. NADLER, and Mr. VALADAO) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend title XVIII of the Social Security Act to provide 

coverage and payment under such title for certain treatments for dialysis-related amyloidosis, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Dialysis-Related Amy5 loidosis Treatment Act of 2024’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 8999 IH

1 SEC. 2. COVERAGE AND PAYMENT FOR TREATMENTS FOR 

2 DIALYSIS-RELATED AMYLOIDOSIS UNDER 

3 THE MEDICARE PROGRAM. 

4 (a) COVERAGE.—Section 1861(s)(2) of the Social Se5 curity Act (42 U.S.C. 1395x(s)(2)), is amended— 

6 (1) in subparagraph (JJ), by inserting ‘‘and’’ 

7 at the end; and 

8 (2) by adding at the end the following new sub9 paragraph: 

10 ‘‘(KK) treatments for dialysis-related amyloi11 dosis (as defined in subsection (nnn));’’. 

12 (b) TREATMENTS FOR DIALYSIS-RELATED AMYLOI13 DOSIS DEFINED.— 

14 (1) IN GENERAL.—Section 1861 of the Social 

15 Security Act (42 U.S.C. 1395x), is amended by add16 ing at the end the following new subsection: 

17 ‘‘(nnn) TREATMENTS FOR DIALYSIS-RELATED AMY18 LOIDOSIS.—The term ‘treatments for dialysis-related amy19 loidosis’ means any item or service that is furnished in 

20 a dialysis facility (freestanding or hospital-based) that is 

21 approved by the Food and Drug Administration for the 

22 treatment of dialysis-related amyloidosis, and any supplies 

23 or services that are provided adjunct to and are necessary 

24 for such treatment.’’. 

25 (2) EXCLUSION FROM RENAL DIALYSIS SERV26 ICES.—Section 1881(b)(14)(B) of the Social SecuVerDate Sep 11 2014 03:21 Aug 16, 2024 Jkt 049200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H8999.IH H8999

kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 8999 IH

1 rity Act (42 U.S.C. 1395rr(b)(14)(B)) is amended 

2 by inserting before the period at the end the fol3 lowing: ‘‘or ‘treatments for dialysis-related amyloi4 dosis’ (as defined in section 1861(nnn))’’. 

5 (c) PAYMENT.—Section 1833(a)(1)(E) of the Social 

6 Security Act (42 U.S.C. 1395l(a)(1)(E)) is amended by 

7 inserting at the end the following: ‘‘except for treatments 

8 for dialysis-related amyloidosis, which may not be included 

9 as a renal dialysis service for purposes of payment under 

10 any prospective payment amount or comprehensive fee es11 tablished under section 1881, and for which payment shall 

12 be made separately in the amount of 100 percent of the 

13 reasonable charges for such items and services,’’. 

14 (d) EFFECTIVE DATE.—The amendments made by 

15 this section shall take effect on the date of the enactment 

16 of this Act. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB